Generex Biotechnology Corp. (fka GNBTQ)

[zumoney]

So they have an upcoming conference call to discuss the phase II of AE37. From what Dr. Mittendorf already said in that ASCO interview I would expect it to be promising. How will this fair in making it go to phase III? who knows.

Biotherapies will be huge over the next decade. Apparently better that regular chemo with less side effects. Using your own body to produce an immune response to fight cancer versus takes toxic chemo meds or using radio therapy. Sounds ideal. Many companies are trying to accomplish this. Will GNBT and the Antigen Express technology be the ones to make breakthroughs? Quite a gamble. Their approach is a little different than the other companies.

The science makes sense but it will take business skills to make it real. Can they continue to fund this project?

Also the whole Oral-lyn push in India is promising. They make it sound that Shreya pharma expects it to get approved.

This would be a big deal if they can start selling this product. Bio Tech is always in the red until they can actually start selling and making money.

Are they too diluted? I want hundreds of thousands of shares.

I am crossing my fingers with this one.